Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Current Deferred Revenue (2020 - 2025)

Definitive Healthcare's Current Deferred Revenue history spans 6 years, with the latest figure at $97.0 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 3.9% year-over-year to $97.0 million; the TTM value through Dec 2025 reached $97.0 million, up 3.9%, while the annual FY2025 figure was $97.0 million, 3.9% up from the prior year.
  • Current Deferred Revenue reached $97.0 million in Q4 2025 per DH's latest filing, up from $92.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $109.7 million in Q1 2025 to a low of $3.4 million in Q1 2022.
  • Average Current Deferred Revenue over 5 years is $89.1 million, with a median of $95.2 million recorded in 2024.
  • Peak YoY movement for Current Deferred Revenue: soared 2998.88% in 2023, then decreased 4.14% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $84.0 million in 2021, then grew by 18.65% to $99.7 million in 2022, then decreased by 2.32% to $97.4 million in 2023, then fell by 4.14% to $93.3 million in 2024, then increased by 3.9% to $97.0 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Current Deferred Revenue are $97.0 million (Q4 2025), $92.0 million (Q3 2025), and $100.9 million (Q2 2025).